CONRAY 30 Drug Patent Profile
✉ Email this page to a colleague
When do Conray 30 patents expire, and what generic alternatives are available?
Conray 30 is a drug marketed by Liebel-flarsheim and is included in one NDA.
The generic ingredient in CONRAY 30 is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CONRAY 30?
- What are the global sales for CONRAY 30?
- What is Average Wholesale Price for CONRAY 30?
Summary for CONRAY 30
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 19 |
| Patent Applications: | 440 |
| DailyMed Link: | CONRAY 30 at DailyMed |
US Patents and Regulatory Information for CONRAY 30
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liebel-flarsheim | CONRAY 30 | iothalamate meglumine | INJECTABLE;INJECTION | 016983-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
